Anticoagulant Reversal
20:59
The Blessing and Curse of Direct Oral Anticoagulants in the Bleeding Patient
1:04:13
Oct. 2024 PEP Talk: Anticoagulation and Reversal Agents
1:00:57
Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
37:41
DOACs in Renal Dysfunction and Liver Disease
25:12
Deborah Siegal, MD, MSc, FRCPC presents Updates in Anticoagulation Reversal
32:51
Reversing oral anticoagulants with a focus on Andexanet Alfa
11:35
Anticoagulation Reversal Strategies
10:46